James Elting

Person

Madison, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Aryl ureas with angiogenisis inhibiting activity
- Patent number 10,653,684
- Issue date May 19, 2020
- Bayer HealthCare LLC
- Jacques Dumas
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Aryl ureas with angiogenesis inhibiting activity
- Patent number 8,618,141
- Issue date Dec 31, 2013
- Bayer HealthCare LLC
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl ureas with angiogenisis inhibiting activity
- Patent number 8,242,147
- Issue date Aug 14, 2012
- Bayer HealthCare LLC
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl ureas with angiogenesis inhibiting activity
- Patent number 7,838,541
- Issue date Nov 23, 2010
- Bayer Healthcare, LLC
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
cDNAs coding for members of the carcinoembryonic antigen family
- Patent number 6,342,583
- Issue date Jan 29, 2002
- Bayer Corporation
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
cDNAs coding for members of the carcinoembryonic antigen family
- Patent number 6,022,958
- Issue date Feb 8, 2000
- Bayer Corporation
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody preparations specifically binding to unique determinants o...
- Patent number 6,013,772
- Issue date Jan 11, 2000
- Bayer Corporation
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of phenylcyclohexylcarboxamides
- Patent number 5,935,983
- Issue date Aug 10, 1999
- Bayer Aktiengesellschaft
- Matthias Muller-Gliemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDNA coding for carcinoembryonic antigen
- Patent number 5,843,761
- Issue date Dec 1, 1998
- Bayer Corporation (Formerly Molecular Diagnostics, Inc.)
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted indole derivatives
- Patent number 5,607,962
- Issue date Mar 4, 1997
- Bayer Aktiengesellschaft
- Matthias M uller-Gliemann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monitoring of NC 50/90 in blood samples of breast cancer patients
- Patent number 5,593,847
- Issue date Jan 14, 1997
- Bayer Corporation
- Thomas R. Barnett
- G01 - MEASURING TESTING
Information Patent Grant
CDNA coding for carcinoembryonic antigen
- Patent number 5,571,710
- Issue date Nov 5, 1996
- Bayer Corporation
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
cDNA coding for carcinoembryonic antigen (CEA)
- Patent number 5,274,087
- Issue date Dec 28, 1993
- Molecular Diagnostics, Inc.
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDNAS coding for members of the carcinoembryonic antigen family
- Patent number 5,231,009
- Issue date Jul 27, 1993
- Molecular Diagnostics, Inc.
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoassay methods using noncross reactive CEA gene family members...
- Patent number 5,200,316
- Issue date Apr 6, 1993
- Miles Inc.
- James Elting
- G01 - MEASURING TESTING
Information Patent Grant
CDNAS coding for members of the carcinoembryonic antigen family
- Patent number 5,122,599
- Issue date Jun 16, 1992
- Molecular Diagnostics, Inc.
- Thomas R. Barnett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxidative denaturation of protein analytes
- Patent number 5,061,790
- Issue date Oct 29, 1991
- Molecular Diagnostics, Inc.
- James J. Elting
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY
- Publication number 20180296541
- Publication date Oct 18, 2018
- Bayer Healthcare LLC
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY
- Publication number 20160015697
- Publication date Jan 21, 2016
- Bayer Healthcare LLC
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY
- Publication number 20120289552
- Publication date Nov 15, 2012
- Bayer HealthCare LLC
- Jacques DUMAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY
- Publication number 20110015195
- Publication date Jan 20, 2011
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Prediction and Prognosis of Cancer, and Monitoring Canc...
- Publication number 20090221010
- Publication date Sep 3, 2009
- James J. Elting
- G01 - MEASURING TESTING
Information Patent Application
Methods for Prediction and Prognosis of Cancer, and Monitoring Canc...
- Publication number 20080311604
- Publication date Dec 18, 2008
- James J. Elting
- G01 - MEASURING TESTING
Information Patent Application
Methods for Prediction and Prognosis of Cancer, and Monitoring Canc...
- Publication number 20080311601
- Publication date Dec 18, 2008
- James J. Elting
- G01 - MEASURING TESTING
Information Patent Application
Aryl Ureas With Angiogenisis Inhibiting Activity
- Publication number 20080227828
- Publication date Sep 18, 2008
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for prediction and prognosis of cancer, and monitoring canc...
- Publication number 20070178494
- Publication date Aug 2, 2007
- James Elting
- G01 - MEASURING TESTING
Information Patent Application
Methods for prediction and prognosis of cancer, and monitoring canc...
- Publication number 20070134670
- Publication date Jun 14, 2007
- Bayer Pharmaceuticals Corporation
- James Kasper
- G01 - MEASURING TESTING
Information Patent Application
Quantitative assays for PDGFR-beta in body fluids
- Publication number 20070037224
- Publication date Feb 15, 2007
- Peter J. Hamer
- G01 - MEASURING TESTING
Information Patent Application
Anti-angiogenesis combination therapies comprising pyridazine or py...
- Publication number 20050019424
- Publication date Jan 27, 2005
- Paul E. Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aryl ureas with raf kinase and angiogenisis inhibiting activity
- Publication number 20040023961
- Publication date Feb 5, 2004
- BAYER CORPORATION
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aryl ureas with angiogenisis inhibiting activity
- Publication number 20030207870
- Publication date Nov 6, 2003
- BAYER CORPORATION
- Jacques Dumas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

James Elting

Person

Patents Grantslast 30 patents

Aryl ureas with angiogenisis inhibiting activity

Aryl ureas with angiogenesis inhibiting activity

Aryl ureas with angiogenisis inhibiting activity

Aryl ureas with angiogenesis inhibiting activity

cDNAs coding for members of the carcinoembryonic antigen family

cDNAs coding for members of the carcinoembryonic antigen family

Antibody preparations specifically binding to unique determinants o...

Use of phenylcyclohexylcarboxamides

CDNA coding for carcinoembryonic antigen

Substituted indole derivatives

Monitoring of NC 50/90 in blood samples of breast cancer patients

CDNA coding for carcinoembryonic antigen

cDNA coding for carcinoembryonic antigen (CEA)

CDNAS coding for members of the carcinoembryonic antigen family

Immunoassay methods using noncross reactive CEA gene family members...

CDNAS coding for members of the carcinoembryonic antigen family

Oxidative denaturation of protein analytes

Patents Applicationslast 30 patents

ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY

ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY

ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY

ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY

Methods for Prediction and Prognosis of Cancer, and Monitoring Canc...

Methods for Prediction and Prognosis of Cancer, and Monitoring Canc...

Methods for Prediction and Prognosis of Cancer, and Monitoring Canc...

Aryl Ureas With Angiogenisis Inhibiting Activity

Methods for prediction and prognosis of cancer, and monitoring canc...

Methods for prediction and prognosis of cancer, and monitoring canc...

Quantitative assays for PDGFR-beta in body fluids

Anti-angiogenesis combination therapies comprising pyridazine or py...

Aryl ureas with raf kinase and angiogenisis inhibiting activity

Aryl ureas with angiogenisis inhibiting activity